Next, a nomogram model based on the four serum tumor markers was constructed to predict the concordance rate between plasma and tissue samples (Figure S6), which revealed a comparable performance in predicting the concordance to CEA combined with CYFRA21‐1. The gene discussed is CEACAM5; the disease is neoplasm.